What Causes Endometriosis Science Has No Clear Answer?

Endometriosis affects an estimated 1 in 10 women of reproductive age, yet the medical community still cannot point to a single definitive cause. The short answer is that science has no single clear answer because endometriosis is likely triggered by a combination of genetic, hormonal, immune, and environmental factors working together. Researchers have several leading theories, but no one theory explains every case of the disease.

What Is Endometriosis Exactly?

Endometriosis is a condition where tissue similar to the lining of the uterus grows outside the uterus. This tissue behaves like normal uterine lining — it thickens, breaks down, and bleeds with each menstrual cycle. But because it has no way to leave the body, it becomes trapped.

This trapped tissue can cause severe pain, heavy periods, and sometimes infertility. The growths can appear on the ovaries, fallopian tubes, the tissue lining the pelvis, and in rare cases, beyond the pelvic organs. The condition ranges from mild to severe, and the amount of tissue does not always match the level of pain a person feels.

What Causes Endometriosis Science Has No Clear Answer — But Here Are the Leading Theories

Scientists have proposed several mechanisms to explain how endometrial-like tissue ends up outside the uterus. Each theory has supporting evidence, but none fully explains every case. Most researchers now believe endometriosis develops through a combination of these processes.

Retrograde menstruation is the oldest and most widely taught theory. It suggests that during menstruation, some menstrual blood flows backward through the fallopian tubes into the pelvic cavity instead of leaving the body. This blood contains endometrial cells that can implant and grow on pelvic organs. Most women experience some retrograde menstruation, yet not all develop endometriosis, so this theory alone does not provide a complete answer.

Cellular metaplasia is another leading theory. This proposes that cells lining the pelvis, which share a common embryonic origin with uterine lining cells, can transform into endometrial-like cells under certain conditions. This would explain how endometriosis can occur in rare cases even in women who have had a hysterectomy or who never menstruate.

How Genetics Influence Endometriosis Risk

Endometriosis clearly runs in families. A woman whose mother or sister has the condition is at significantly higher risk of developing it herself. Research on identical twins shows that when one twin has endometriosis, the other twin has a high chance of having it too.

Scientists have identified multiple genetic variations associated with the condition. These variations affect genes involved in hormone signaling, inflammation, and tissue repair. But genetics alone do not determine the outcome. Having the genetic markers does not guarantee a woman will develop endometriosis, and many women with the condition have no family history at all.

This pattern — genetic predisposition combined with environmental triggers — is called a multifactorial model. It is the most widely accepted framework for understanding the disease today.

The Role of the Immune System in Endometriosis

The immune system plays a central role in whether retrograde menstrual tissue survives outside the uterus. In most women, immune cells in the pelvic cavity recognize and clear away displaced endometrial cells. In women with endometriosis, this clearance process appears to fail.

Research shows that women with endometriosis have altered immune activity in the pelvic cavity. Natural killer cells, which normally destroy abnormal cells, show reduced activity. Inflammatory molecules are present at higher levels, which may help endometrial tissue attach and grow.

This immune dysfunction may be inherited, or it may develop over time. Some researchers believe that the immune changes are a response to the endometrial tissue itself, creating a cycle where the presence of the tissue further impairs immune clearance.

Hormonal Factors Beyond Estrogen

Endometriosis is an estrogen-dependent disease. The growths need estrogen to survive and proliferate, which is why the condition typically affects women during their reproductive years and often improves after menopause. But estrogen alone does not explain why some women develop the disease and others do not.

Hormone resistance may be part of the answer. Some research suggests that women with endometriosis have tissue that responds abnormally to progesterone, the hormone that normally counterbalances estrogen. If endometrial-like tissue does not respond properly to progesterone, it may continue to grow and shed in ways that fuel inflammation and pain.

Environmental chemicals that mimic estrogen — called endocrine-disrupting compounds — have also been studied. Some research suggests that early exposure to certain chemicals, such as dioxins or BPA, may increase risk. The evidence is limited and mostly from animal studies, so no firm conclusions can be drawn about human exposure levels.

Why the Answer Is Still Unknown

The reason science cannot name one single cause is that endometriosis is not one simple disease. It is likely a syndrome — a collection of related conditions that share similar symptoms but may have different underlying causes.

A woman with mild endometriosis on the surface of her pelvis may have a completely different disease process than a woman with deep ovarian cysts. Both may be diagnosed with endometriosis, but their conditions may respond to different treatments. This heterogeneity makes it difficult for researchers to identify a unified cause.

Diagnosis delays compound the problem. On average, women wait years between the onset of symptoms and a formal diagnosis. This delay means researchers often study women with advanced disease, which may not represent the earliest stages of the condition.

What This Means for Diagnosis and Treatment

Because the cause is not fully understood, treatment focuses on managing symptoms rather than addressing an underlying root cause. The two main approaches are hormonal suppression and surgical removal of endometrial-like tissue.

Hormonal treatments — such as birth control pills, progestins, and GnRH agonists — work by reducing or stopping ovulation and menstruation. This limits estrogen exposure and can shrink endometrial growths. These treatments are effective for many women but do not cure the disease, and symptoms often return when treatment stops.

Surgery to excise endometrial lesions can provide significant relief, but the condition recurs in a substantial number of cases within a few years. Neither approach addresses the immune dysfunction or genetic factors that may have allowed the disease to develop in the first place.

Research is moving toward identifying subtypes of endometriosis based on genetic and molecular markers. The hope is that this will lead to targeted treatments that address the specific mechanisms driving each woman’s disease. That work is still in early stages.

What Researchers Are Investigating Now

Current research is focusing on several promising areas. Stem cell research is exploring the possibility that endometrial-like tissue originates from bone marrow-derived stem cells that travel to the pelvic cavity. This would explain how endometriosis can occur in locations far from the uterus.

Microbiome research is examining whether the bacterial community in the reproductive tract differs in women with endometriosis. Some studies suggest that certain bacterial profiles are associated with more severe disease, but the direction of this relationship is not yet clear.

Pain research is investigating why some women with extensive disease feel little pain while others with minimal disease experience debilitating symptoms. This work focuses on nerve growth within lesions and changes in pain processing in the central nervous system.